MPJE study guide
MPJE · Work through your exam, one topic at a time.
The Multistate Pharmacy Jurisprudence Examination (MPJE) is the pharmacy law licensure examination: it tests federal statutes and regulations layered on top of the statutes, board rules, and regulatory guidance of one specific jurisdiction. Candidates for pharmacist licensure in most U.S. The MPJE study guide has 6 sections and about 1,989 words.
01Federal Statutes, Regulations, and Agency Guidance
Federal law governs the drug product and the closed chain of distribution; the states govern the practice of pharmacy. Knowing which actor a statute addresses is the entire game.
332 words, about 2 min02Jurisdiction-Specific Statutes, Board Rules, and Regulatory Guidance
Every state has a pharmacy practice act (statute) and board regulations (rules). Statutes outrank rules, and a rule that conflicts with its statute is invalid.
369 words, about 2 min03Controlled Substances: Scheduling, Registration, Ordering, Recordkeeping, and Prescriptions
Schedules I through V rest on three findings: abuse potential, accepted medical use, and dependence liability. Schedule I has no accepted medical use.
358 words, about 2 min04Prescription Processing, Dispensing, Labeling, Counseling, and Patient Care
Screen for the essential elements: patient identity, drug, strength, dosage form, quantity, directions, date, prescriber identity and signature (or valid electronic signature), and refills authorized. An electronic prescription for a controlled substance requires EPCS-compliant two-factor authentication and an audit trail.
288 words, about 1 min05Licensure, Registration, Certification, and Operations/Inventory Management
License is state-granted authority to practice or operate (pharmacist license, pharmacy or facility license, nonresident pharmacy registration). Registration is an enumerated listing with a government agency (DEA registration, state technician registration, with some states also requiring certification).
315 words, about 2 min06Compounding, Nonprescription/BTC Products, and Special Distribution Channels
The dividing question is whether the preparation is patient-specific and prescription-based. A 503A traditional compounder is a licensed pharmacy or federal facility that compounds on a patient-specific prescription or a documented prescriber-established relationship; it must avoid "essentially a copy" of a commercially available product unless a change produces a significant difference for the patient; bulk drug substances must comply with an applicable USP/NF monograph and appear on FDA's 503A bulks list with a certificate of analysis from a registered establishment; out-of-state distribution is capped absent an MOU; and USP <795 (nonsterile), <797 (sterile), and <800 (hazardous) standards apply.
327 words, about 2 min